The ability of inflammatory markers to recognize infection in cancer patients with fever at admission

被引:9
|
作者
Rao, Lubei [1 ]
Zhang, Kaijiong [1 ]
Luo, Huaichao [1 ]
He, Shuya [1 ]
Li, Yuping [1 ]
Liu, Chang [1 ]
Yang, Ying [2 ]
Wang, Dongsheng [1 ]
机构
[1] Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, Dept Clin Lab,Sch Med, 55,Sect 4,Renmin South Rd, Chengdu, Sichuan, Peoples R China
[2] Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, Dept Informat,Sch Med, Chengdu, Peoples R China
关键词
Procalcitonin; C-reactive protein; Interleukin-6; Interleukin-10; Infection; Cancer; C-REACTIVE PROTEIN; BLOOD-STREAM INFECTIONS; RESPONSE SYNDROME SIRS; FEBRILE NEUTROPENIA; SERUM PROCALCITONIN; SEPSIS; DIAGNOSIS; INTERLEUKIN-6; UTILITY; IDENTIFICATION;
D O I
10.1007/s12026-022-09299-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Infection is one of the main causes of death in cancer patients. Accurate identification of fever caused by infection could avoid unnecessary antibiotic treatment and hospitalization. This study evaluated the diagnostic value of procalcitonin (PCT), C-reactive protein (CRP), interleukin-6 (IL-6), interleukin-10 (IL-10), and other commonly used inflammatory markers in suspected infected adult cancer patients with fever, for better use of antibiotics. This research retrospective analyzed the clinical data of 102 adult cancer patients with fever and compared the serum levels of commonly used inflammatory markers for different fever reasons. Receiver-operating characteristic (ROC) curve and logistic regression analyses were performed. In adult cancer patients with fever, the serum PCT, CRP, IL-6, and IL-10 levels of infected patients were significantly higher than uninfected patients (median 1.19 ng/ml vs 0.14 ng/ml, 93.11 mg/l vs 56.55 mg/l, 123.74 pg/ml vs 47.35 pg/ml, 8.74 pg/ml vs 3.22 pg/ml; Mann-Whitney p = 0.000, p = 0.009, p = 0.004, p = 0.000, respectively). The ROC area under the curve(AUC) was 0.769 (95% confidence interval (CI) 0.681-0.857; p = 0.000) for PCT, 0.664 (95% CI 0.554-0.775; p = 0.009) for CRP, 0.681(95% CI 0.576-0.785; p = 0.004) for IL-6, and 0.731(95% CI 0.627-0.834; p = 0.000) for IL-10. PCT had specificity of 96.67% and positive predictive value (PPV) of 97.6%, when the cut-off value is set as 0.69 ng/ml. The serum IL-6 and IL-10 levels also had significant differences between the infected and uninfected cancer patients with advanced disease (median 128.92 pg/ml vs 36.40 pg/ml, 8.05 pg/ml vs 2.92 pg/ml; Mann-Whitney p = 0.003, p = 0.001, respectively). For the patients with neutropenia, IL-6 and IL-10 had higher AUC of 0.811 and 0.928, respectively. With a cut-off of 9.10 pg/ml, IL-10 had the highest sensitivity 83.33% and specificity 100%. In adult cancer patients, PCT had the best performance compared to CRP, IL-6, and IL-10 in differentiating infected from uninfected causes of fever, with high specificity and PPV. IL-6 and IL-10 might be useful in cancer patients with severe bloodstream infections and advanced disease. However, for patients with neutropenia, IL-10 might be more valuable than PCT in diagnosing infection.
引用
收藏
页码:667 / 677
页数:11
相关论文
共 50 条
  • [21] SERUM LEVEL OF HMGB1 PROTEIN AND INFLAMMATORY MARKERS IN PATIENTS WITH SECONDARY PERITONITIS: TIME COURSE AND THE ASSOCIATION WITH CLINICAL STATUS
    Milic, Ljiljana
    Grigorov, Ilijana
    Krstic, Slobodan
    Ceranic, Miljan S.
    Jovanovic, Bojan
    Stevanovic, Jelena
    Pesko, Predrag
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2017, 36 (01) : 44 - 53
  • [22] Differential diagnosis between bacterial infection and neoplastic fever in patients with advanced urological cancer: The role of procalcitonin
    Yaegashi, Hiroshi
    Izumi, Kouji
    Kitagawa, Yasuhide
    Kadono, Yoshifumi
    Konaka, Hiroyuki
    Mizokami, Atsushi
    Namiki, Mikio
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 (01) : 104 - 106
  • [23] Are presepsin and resistin better markers for bacterial infection in patients with decompensated liver cirrhosis?
    Fischer, Petra
    Grigoras, Crina
    Bugariu, Anca
    Nicoara-Farcau, Oana
    Stefanescu, Horia
    Benea, Andreea
    Hadade, Adina
    Margarit, Simona
    Sparchez, Zeno
    Tantau, Marcel
    Ionescu, Daniela
    Procopet, Bogdan
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (12) : 1685 - 1691
  • [24] Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade
    Nardone, Valerio
    Giannicola, Rocco
    Bianco, Giovanna
    Giannarelli, Diana
    Tini, Paolo
    Pastina, Pierpaolo
    Falzea, Antonia Consuelo
    Macheda, Sebastiano
    Caraglia, Michele
    Luce, Amalia
    Zappavigna, Silvia
    Mutti, Luciano
    Pirtoli, Luigi
    Giordano, Antonio
    Correale, Pierpaolo
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [25] Role of Inflammatory Markers in Diagnosing Diabetic Foot Infection A Meta-Analysis
    Majeed, Aneela
    Mushtaq, Adeela
    Iftikhar, Ahmad
    Zahid, Umar
    Malik, Mustafa Nadeem
    Razzaq, Faryal
    Al Mohajer, Mayar
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2019, 27 (05) : 251 - 259
  • [26] Interleukin-6 and other inflammatory markers in diagnosis of periprosthetic joint infection
    Elgeidi, Adham
    Elganainy, Abd Elrahman
    Abou Elkhier, Noha
    Rakha, Shirien
    INTERNATIONAL ORTHOPAEDICS, 2014, 38 (12) : 2591 - 2595
  • [27] Fever in the new millennium: a review of recent studies of markers of serious bacterial infection in febrile children
    Hsiao, AL
    Baker, MD
    CURRENT OPINION IN PEDIATRICS, 2005, 17 (01) : 56 - 61
  • [28] Preoperatively elevated serum inflammatory markers increase the risk of periprosthetic joint infection following total knee arthroplasty in patients with osteoarthritis
    Xu, Chi
    Guo, Heng
    Qu, Pengfei
    Fu, Jun
    Kuo, Feng-Chih
    Chen, Ji-Ying
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2018, 14 : 1719 - 1724
  • [29] Inflammatory markers and elderly patients with stroke
    AntonelloSilvestri
    CristianaVitale
    PasqualeGaletta
    DanielaOnorati
    MassimoFini
    GiuseppeMCRosano
    Journal of Geriatric Cardiology, 2004, (01) : 44 - 48
  • [30] Procalcitonin as a biomarker for infection-related mortality in cancer patients
    Sedef, Ali M.
    Kose, Fatih
    Mertsoylu, Huseyin
    Ozyilkan, Ozgur
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2015, 9 (02) : 168 - 173